Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Marcus Ruscetti,Bill Quach,Eman L. Dadashian,David J. Mulholland,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22405865.v1

2023-01-01

Abstract:Supplementary Figure Legends. Legend for Supplementary Figures S1-S5.

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figure S3 from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Marcus Ruscetti,Bill Quach,Eman L. Dadashian,David J. Mulholland,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22405856

2023-01-01

Abstract:Supplementary Figure S3. EMT-like and mesenchymal tumor cells have enhanced tumor-initiating capacity in vivo.
Supplementary Methods from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Marcus Ruscetti,Bill Quach,Eman L. Dadashian,David J. Mulholland,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22405847

2023-01-01

Abstract:Supplementary Methods. Description of additional methods and procedures used in the study.
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Xiao Lin,Dae Joong Kim,Clayton L. Davis,James V. McCann,James M. Dunleavey,Alissa K. Vanderlinden,Nuo Xu,Samantha G. Pattenden,Stephen V. Frye,Xin Xu,Mark Onaitis,Elizabeth Monaghan-Benson,Keith Burridge,Andrew C. Dudley

DOI: https://doi.org/10.1158/0008-5472.22406702

2023-01-01

Abstract:Legends for Supplemental Figures S1-S7.
Supplementary Data Legends and Methods from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Xiaoming Ju,Adam Ertel,Mathew C. Casimiro,Zuoren Yu,Hua Meng,Peter A. McCue,Robin G. Walters,Paolo Fortina,Michael P. Lisanti,Richard G. Pestell

DOI: https://doi.org/10.1158/0008-5472.22396404

2023-01-01

Abstract:PDF file - 132KB, Legends for Supplementary Table 1 and Figures 1-7, and Supplementary Methods
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplementary Figure Legends from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Ting-Ting Yan,Lin-Lin Ren,Chao-Qin Shen,Zhen-Hua Wang,Ya-Nan Yu,Qian Liang,Jia-Yin Tang,Ying-Xuan Chen,Dan-Feng Sun,Witold Zgodzinski,Marek Majewski,Piotr Radwan,Ilona Kryczek,Ming Zhong,Jinxian Chen,Qiang Liu,Weiping Zou,Hao-Yan Chen,Jie Hong,Jing-Yuan Fang

DOI: https://doi.org/10.1158/0008-5472.22417241

2023-01-01

Abstract:This file contains figure legends corresponding to supplementary figures.
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Xueying Mao,Yongwei Yu,Lara K. Boyd,Guoping Ren,Dongmei Lin,Tracy Chaplin,Sakunthala C. Kudahetti,Elzbieta Stankiewicz,Liyan Xue,Luis Beltran,Manu Gupta,R. Tim D. Oliver,Nick R. Lemoine,Daniel M. Berney,Bryan D. Young,Yong-Jie Lu

DOI: https://doi.org/10.1158/0008-5472.22383381.v1

2023-01-01

Abstract:Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Su Li,Yongli Luo,Yang Liu,Jing Yang,Chao Yao,Cheng Fang,Juanjuan Shan,Jun Chen,Fangfang Li,Limei Liu,Chungang Liu,Yong Xu,Lupin Jiang,Deyu Guo,Jesús Prieto,Matías A. Ávila,Junjie Shen,Cheng Qian

DOI: https://doi.org/10.1158/0008-5472.22412124.v1

2023-01-01

Abstract:Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Jeff Hsu,Colin Chong,Jeffrey Serrill,Levina Goon,Joan Balayan,Eric N. Johnson,Grachelle Lorenzana,Sharon Wu,Kevin G. Leong,Theodore J. Yun,Yong Wang,Faming Jiang,Lynne Bannen,Peter Lamb,Wei Xu,Peiwen Yu

DOI: https://doi.org/10.1158/1535-7163.22523460

2023-01-01

Abstract:Supplementary Figures and Tables with adjoining Legends
Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Li Liu,Xue Bai,Jian Wang,Xiaonan Tang,Dehua Wu,Shasha Du,Xiu-Ju Du,Yao-Wei Zhang,Hai‐Liang Zhu,Yuan Fang,Zhimou Guo,Qiandong Zeng,Xuejun Guo,Zhu Li,Zhong‐Yi Dong

DOI: https://doi.org/10.1158/1078-0432.22471917.v1

2023-01-01

Abstract:Supplementary figure legends
Supplementary Figures 1-7 from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Xiaoming Ju,Adam Ertel,Mathew C. Casimiro,Zuoren Yu,Hua Meng,Peter A. McCue,Robin G. Walters,Paolo Fortina,Michael P. Lisanti,Richard G. Pestell

DOI: https://doi.org/10.1158/0008-5472.22396401

2023-01-01

Abstract:PDF file - 675KB, Supplementary Figure 1: Histology of tumors induced by transformed prostate cancer cell lines in mice. Supplementary Figure 2: vWF and KLK3 staining of tumors induced by transformed cell lines. Supplementary Figure 3: Gene Ontology enrichment analysis. Supplementary Figure 4: c-Myc prostate cancer cell line gene expression. Supplementary Figure 5: Kaplan Meier curves for high and low expression populations for the c-Myc overexpression signature. Supplementary Figure 6: Androgen responsiveness of transformed PEC lines. Supplementary Figure 7: CK5 or CK8 IFC staining in cell lines and tumor lung metastasis.
Supplementary Figure Legends 1-6 from Lin−Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model

David J. Mulholland,Li Xin,Ashkan Morim,Devon Lawson,Owen Witte,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22379546.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-6 from Lin−Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model
Supplementary Figure legend from ETV1-Positive Cells Give Rise to BRAFV600E-Mutant Gastrointestinal Stromal Tumors

Leili Ran,Devan Murphy,Jessica Sher,Zhen Cao,Shangqian Wang,Edward Walczak,Youxin Guan,Yuanyuan Xie,Shipra Shukla,Yu Zhan,Cristina R. Antonescu,Yu Chen,Ping Chi

DOI: https://doi.org/10.1158/0008-5472.22414656.v1

2023-01-01

Abstract:Supplementary Figure legend
Supplementary Figure Legends 1-3 from Amplification and Overexpression of cttn (ems1) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Man‐Li Luo,Xiaoming Shen,Yu Zhang,Wei Fang,Xin Xu,Cheng Yan,Xun Zhang,Yan Sun,Qimin Zhan,Ming‐Rong Wang

DOI: https://doi.org/10.1158/0008-5472.22367075.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-3 from Amplification and Overexpression of CTTN (EMS1) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance
Supplementary Figures 1-7 from Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

David J. Mulholland,Naoko Kobayashi,Marcus Ruscetti,Allen Zhi,Linh M. Tran,Jiaoti Huang,Martin Gleave,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22391619

2023-01-01

Abstract:PDF file - 1.5MB
Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Xin Zheng,Xiaolei Fan,Binqing Fu,Ming–Hua Zheng,Aimei Zhang,Kai Zhong,Jun Yan,Rui Sun,Zhigang Tian,Wei H

DOI: https://doi.org/10.1158/0008-5472.22414839.v1

2023-01-01

Abstract:Supplementary Figure 1-6 legends

Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure S3 from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Methods from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Supplementary Data Legends and Methods from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Supplementary Figures 1-7 from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Supplementary Figure Legends 1-6 from Lin<sup>−</sup>Sca-1<sup>+</sup>CD49f<sup>high</sup> Stem/Progenitors Are Tumor-Initiating Cells in the <i>Pten</i>-Null Prostate Cancer Model

Supplementary Figure legend from ETV1-Positive Cells Give Rise to <i>BRAF<sup>V600E</sup></i>-Mutant Gastrointestinal Stromal Tumors

Supplementary Figure Legends 1-3 from Amplification and Overexpression of <i>cttn</i> (<i>ems1</i>) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Supplementary Figures 1-7 from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Supplementary Figure Legends from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure S3 from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Methods from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Supplementary Data Legends and Methods from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced &lt;i&gt;let-7g&lt;/i&gt; Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends from Mir-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Supplementary Figures 1-7 from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Supplementary Figure Legends 1-6 from Lin&lt;sup&gt;−&lt;/sup&gt;Sca-1&lt;sup&gt;+&lt;/sup&gt;CD49f&lt;sup&gt;high&lt;/sup&gt; Stem/Progenitors Are Tumor-Initiating Cells in the &lt;i&gt;Pten&lt;/i&gt;-Null Prostate Cancer Model

Supplementary Figure legend from ETV1-Positive Cells Give Rise to &lt;i&gt;BRAF&lt;sup&gt;V600E&lt;/sup&gt;&lt;/i&gt;-Mutant Gastrointestinal Stromal Tumors

Supplementary Figure Legends 1-3 from Amplification and Overexpression of &lt;i&gt;cttn&lt;/i&gt; (&lt;i&gt;ems1&lt;/i&gt;) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Supplementary Figures 1-7 from &lt;i&gt;Pten&lt;/i&gt; Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Supplementary Figure Legends from EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends 1-6 from Lin<sup>−</sup>Sca-1<sup>+</sup>CD49f<sup>high</sup> Stem/Progenitors Are Tumor-Initiating Cells in the <i>Pten</i>-Null Prostate Cancer Model

Supplementary Figure legend from ETV1-Positive Cells Give Rise to <i>BRAF<sup>V600E</sup></i>-Mutant Gastrointestinal Stromal Tumors

Supplementary Figure Legends 1-3 from Amplification and Overexpression of <i>cttn</i> (<i>ems1</i>) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance

Supplementary Figures 1-7 from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells